3/13
08:04 pm
rxrx
Jim Cramer on Recursion Pharmaceuticals: “It's a Let Down, Big Let Down” [Yahoo! Finance]
Low
Report
Jim Cramer on Recursion Pharmaceuticals: “It's a Let Down, Big Let Down” [Yahoo! Finance]
3/10
10:44 pm
rxrx
Is Recursion Pharmaceuticals (RXRX) Pricing Reflect Recent 1-Year Share Slump Accurately [Yahoo! Finance]
Neutral
Report
Is Recursion Pharmaceuticals (RXRX) Pricing Reflect Recent 1-Year Share Slump Accurately [Yahoo! Finance]
3/9
10:36 pm
rxrx
Recursion's First AI Clinical Proof Links Pipeline Progress With Valuation Gap [Yahoo! Finance]
Low
Report
Recursion's First AI Clinical Proof Links Pipeline Progress With Valuation Gap [Yahoo! Finance]
3/9
08:36 pm
rxrx
What Makes Recursion Pharmaceuticals (RXRX) So Attractive [Yahoo! Finance]
Low
Report
What Makes Recursion Pharmaceuticals (RXRX) So Attractive [Yahoo! Finance]
3/8
12:30 pm
rxrx
Can This AI Stock Bounce Back in 2026? [Yahoo! Finance]
Low
Report
Can This AI Stock Bounce Back in 2026? [Yahoo! Finance]
3/6
12:25 pm
rxrx
BoFA Lowers PT on Recursion Pharmaceuticals (RXRX), Keeps a Hold Rating [Yahoo! Finance]
Low
Report
BoFA Lowers PT on Recursion Pharmaceuticals (RXRX), Keeps a Hold Rating [Yahoo! Finance]
3/2
04:43 pm
rxrx
Recursion: Nvidia Sells Out, Collaboration Still Alive, Data Ahead [Seeking Alpha]
Low
Report
Recursion: Nvidia Sells Out, Collaboration Still Alive, Data Ahead [Seeking Alpha]
2/28
07:02 pm
rxrx
Recursion's REC-4881 Milestone And Cash Runway Shift Risk Reward Profile [Yahoo! Finance]
Low
Report
Recursion's REC-4881 Milestone And Cash Runway Shift Risk Reward Profile [Yahoo! Finance]
2/25/2026
06:30 am
RXRX
recursion pharmaceuticals, inc. - class a
BEAT
Report
-1.8%
recursion pharmaceuticals, inc. - class a
11/5/2025
06:30 am
RXRX
recursion pharmaceuticals, inc. - class a
BEAT
Report
1.6%
recursion pharmaceuticals, inc. - class a
8/5/2025
06:30 am
RXRX
recursion pharmaceuticals, inc. - class a
MISS
Report
-6.9%
recursion pharmaceuticals, inc. - class a
5/5/2025
06:00 am
RXRX
recursion pharmaceuticals, inc. - class a
MISS
Report
-15.5%
recursion pharmaceuticals, inc. - class a
Bank of America Corporation
3/17
10:53 am
rxrx
Form 144 RECURSION PHARMACEUTICAL Filed by: Taylor Ben R
Low
Report
Form 144 RECURSION PHARMACEUTICAL Filed by: Taylor Ben R
3/11
05:41 pm
rxrx
Form 4 RECURSION PHARMACEUTICAL For: Mar 09 Filed by: Khan Najat
Medium
Report
Form 4 RECURSION PHARMACEUTICAL For: Mar 09 Filed by: Khan Najat
3/11
05:41 pm
rxrx
Form 4 RECURSION PHARMACEUTICAL For: Mar 09 Filed by: Gibson Christopher
Medium
Report
Form 4 RECURSION PHARMACEUTICAL For: Mar 09 Filed by: Gibson Christopher
3/9
01:45 pm
rxrx
Form 144 RECURSION PHARMACEUTICAL Filed by: Khan Najat
Medium
Report
Form 144 RECURSION PHARMACEUTICAL Filed by: Khan Najat
3/4
04:39 pm
rxrx
Form 4 RECURSION PHARMACEUTICAL For: Mar 03 Filed by: Borgeson Blake
Low
Report
Form 4 RECURSION PHARMACEUTICAL For: Mar 03 Filed by: Borgeson Blake
3/3
12:45 pm
rxrx
Form 144 RECURSION PHARMACEUTICAL Filed by: Borgeson Blake
Low
Report
Form 144 RECURSION PHARMACEUTICAL Filed by: Borgeson Blake
2/25
06:48 am
rxrx
Form S-8 RECURSION PHARMACEUTICAL
Medium
Report
Form S-8 RECURSION PHARMACEUTICAL
2/25
06:45 am
rxrx
Form 424B5 RECURSION PHARMACEUTICAL
Medium
Report
Form 424B5 RECURSION PHARMACEUTICAL
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register